← Back to Analyst Consensus 
REPL Buy
Replimune Group, Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 26, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 7, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 7, 2026 | Wedbush | upgrade | Neutral → Outperform | — | 58% |
| Aug 4, 2026 | Leerink Partners | upgrade | Market Perform → Outperform | — | 51% |
| Jul 31, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jul 31, 2026 | Cantor Fitzgerald | upgrade | Neutral → Overweight | — | 50% |
| Jun 30, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jun 26, 2026 | JP Morgan | upgrade | Neutral → Overweight | — | 54% |
| Jun 1, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| May 29, 2026 | JP Morgan | upgrade | Underweight → Neutral | — | 54% |
| Apr 13, 2026 | Cantor Fitzgerald | downgrade | Overweight → Neutral | — | 50% |
| Apr 13, 2026 | Leerink Partners | downgrade | Outperform → Market Perform | — | 51% |
| Apr 13, 2026 | JP Morgan | downgrade | Neutral → Underweight | — | 54% |
| Apr 13, 2026 | Wedbush | downgrade | Outperform → Neutral | — | 58% |
| Apr 13, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Apr 13, 2026 | HC Wainwright & Co. | downgrade | Buy → Sell | — | 44% |
| Feb 5, 2026 | Piper Sandler | maintain | Overweight → Overweight | $14 | 54% |
| Feb 4, 2026 | Wedbush | maintain | Outperform → Outperform | $19 | 58% |
| Nov 3, 2025 | BMO Capital | upgrade | Underperform → Market Perform | $11 | 53% |
| Oct 27, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $12 | 44% |
| Oct 20, 2025 | JP Morgan | upgrade | Underweight → Neutral | $11 | 54% |
| Oct 20, 2025 | Leerink Partners | upgrade | Market Perform → Outperform | $13 | 51% |
| Oct 20, 2025 | Wedbush | upgrade | Neutral → Outperform | $18 | 58% |
| Sep 19, 2025 | JP Morgan | downgrade | Neutral → Underweight | $0 | 54% |
| Sep 8, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Jul 30, 2025 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $0 | 50% |
| Jul 23, 2025 | BMO Capital | downgrade | Outperform → Underperform | $2 | 53% |
| Jul 23, 2025 | Barclays | downgrade | Overweight → Equal-Weight | $3 | 53% |
| Jul 23, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Jul 22, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $3 | 51% |
| Jul 22, 2025 | JP Morgan | downgrade | Overweight → Neutral | $9 | 54% |
| Jul 22, 2025 | Jefferies | maintain | Buy → Buy | $6 | 52% |
| Jul 22, 2025 | Wedbush | downgrade | Outperform → Neutral | $4 | 58% |
| Jul 16, 2025 | JP Morgan | maintain | Overweight → Overweight | $19 | 54% |
| Jul 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Jun 20, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $0 | 50% |
| Jun 2, 2025 | Piper Sandler | maintain | Overweight → Overweight | $22 | 54% |
| Feb 26, 2025 | JP Morgan | maintain | Overweight → Overweight | $18 | 54% |
| Feb 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $22 | 44% |
| Jan 22, 2025 | BMO Capital | maintain | Outperform → Outperform | $27 | 53% |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $21 | 44% |
| Dec 4, 2024 | Jefferies | maintain | Buy → Buy | $19 | 52% |
| Nov 22, 2024 | BMO Capital | maintain | Outperform → Outperform | $18 | 53% |
| Nov 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Sep 24, 2024 | JP Morgan | maintain | Overweight → Overweight | $17 | 54% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Sep 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Aug 27, 2024 | Roth MKM | initiate | — → Buy | $17 | 52% |
| Aug 13, 2024 | JP Morgan | maintain | Overweight → Overweight | $14 | 54% |
Price Target Trend
Jun 26, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days